지프라시돈 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "지프라시돈" in Korean language version.

refsWebsite

Global rank Korean rank

4^th place

4^th place

2^nd place

3^rd place

3,984^th place

1,245^th place

447^th place

433^rd place

399^th place

141^st place

doi.org

dx.doi.org

Stahl; Chiara Mattei; Maria Paola Rapagnani (February 2011). “Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?”. 《Journal of Central Nervous System Disease》 3: 1–16. doi:10.4137/JCNSD.S4138. PMC 3663608. PMID 23861634.
Nicolson, SE; Nemeroff, CB (December 2007). “Ziprasidone in the treatment of mania in bipolar disorder”. 《Neuropsychiatr Dis Treat》 3 (6): 823–34. doi:10.2147/NDT.S794. PMC 2656324. PMID 19300617.

drugs.com

“Ziprasidone Monograph for Professionals”. 《Drugs.com》 (영어). American Society of Health-System Pharmacists. 2019년 5월 8일에 확인함.

fda.gov

FDA Psychopharmacological Drugs Advisory Committee (2000년 7월 19일). “Briefing Document for Zeldoz Capsules” (PDF). FDA.

nih.gov

ncbi.nlm.nih.gov

Stahl; Chiara Mattei; Maria Paola Rapagnani (February 2011). “Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?”. 《Journal of Central Nervous System Disease》 3: 1–16. doi:10.4137/JCNSD.S4138. PMC 3663608. PMID 23861634.
Nicolson, SE; Nemeroff, CB (December 2007). “Ziprasidone in the treatment of mania in bipolar disorder”. 《Neuropsychiatr Dis Treat》 3 (6): 823–34. doi:10.2147/NDT.S794. PMC 2656324. PMID 19300617.

tga.gov.au

ebs.tga.gov.au

“Product Information: Zeldox IM (ziprasidone mesilate)”. Australia Therapeutic Goods Administration. 2016년 2월 24일.
“Product Information: Zeldox (ziprasidone hydrochloride)”. Australia Therapeutic Goods Administration. 2016년 2월 24일.